Ligand Pharmaceuticals Inc (NAS:LGND)
$ 122.55 -1.78 (-1.43%) Market Cap: 2.32 Bil Enterprise Value: 2.10 Bil PE Ratio: 48.82 PB Ratio: 2.73 GF Score: 75/100

Ligand Pharmaceuticals Inc Virtual Investor Day Transcript

Oct 20, 2020 / 03:00PM GMT
Release Date Price: $55.32 (-4.58%)
Operator

Hello, and welcome to today's webcast. My name is Renz, and I'll be your event specialist today. (Operator Instructions) Today's webcast is being recorded. (Operator Instructions)

It is now my pleasure to turn todayâs program over to Mr. Patrick O'Brien, Senior Vice President, Investor Relations. Sir, the floor is yours.

Patrick O;Brien
Ligand Pharmaceuticals Incorporated - SVP of IR

' -

Thank you, and welcome to the 2020 Virtual Ligand Investor and Analyst Day Conference Call. Consistent with the recommendations for social distancing, most of our speakers for today's call are in separate locations. Presenting today for Ligand will be John Higgins, CEO; Matt Foehr, COO; Matt Korenberg, CFO; Vince Antle, SVP, Technical Operations and Quality Assurance; and Patrick Lucy, SVP and CBO, Protein Expression business. We are also very pleased to have 2 guest speakers as well. Monica Tijerina, Executive Director, Formulations and Process Development from Gilead; Matt Davis, Infectious Disease clinical pharmacist at the UCLA Ronald Reagan Medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot